NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 37 filers reported holding NEUBASE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22 | -67.2% | 120,000 | -65.7% | 0.03% | -67.5% |
| Q4 2022 | $67 | -100.0% | 350,000 | -22.2% | 0.08% | -59.8% |
| Q3 2022 | $178,000 | -54.2% | 450,000 | +21.6% | 0.20% | -51.9% |
| Q2 2022 | $389,000 | -36.3% | 370,000 | +13.8% | 0.41% | -19.3% |
| Q1 2022 | $611,000 | +44.8% | 325,000 | +116.7% | 0.51% | +60.8% |
| Q4 2021 | $422,000 | +55.7% | 150,000 | +100.0% | 0.32% | +57.9% |
| Q3 2021 | $271,000 | – | 75,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |